Testing a breathalyser for lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new breathalyser device that may help diagnose lung cancer by analyzing your breath. It is a pilot study, meaning it is early research to see if the device works. You may be eligible if you have untreated advanced lung cancer, or you are a healthy volunteer to compare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 16 years old.
- You must be able to give written consent to take part.
- You must have either advanced lung cancer (non-small cell or small cell) that has not yet been treated with chemotherapy or radiation, OR have had early-stage lung cancer treated in the past, OR be a healthy relative or friend of a lung cancer patient with no personal history of cancer.
- You must not have a current respiratory infection like a cold, flu, or bronchitis.
- You must be able to provide a breath sample using a special device (the breathalyser).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple breath test to detect liver cancer and monitor liver health. It is looking for patients with liver cancer, liver cirrhosis, primary sclerosing cholangitis, or people with normal livers to see if the breath test can help tell the difference.
This study tests a new breath test to find early signs of lung cancer in people at high risk. It looks for cancer biomarkers in the air you breathe out. If you are a heavy smoker between 55 and 74, this trial may help detect lung cancer earlier.
This study checks tiny pieces of DNA from a sample taken during a breathing-tube biopsy (EBUS-TBNA) to better identify certain lung cancer changes. It may help doctors learn more about the type of lung cancer and, in some cases, why targeted treatments stop working.
This study tests a new device that analyzes your breath to help monitor diseases. It may help doctors track conditions early, before treatment begins.
This study uses a special device called an electronic nose to analyze your breath and look for signs of several diseases. It is a simple, non-invasive test that may help find health issues earlier, possibly leading to better treatment outcomes.
This study is testing new breath and blood tests to detect lung cancer. It may help find better ways to diagnose and monitor non-small cell lung cancer.
Hear when a new Advanced Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.